Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Javier Casinello"'
Autor:
Guillermo de Velasco, Teresa Alonso-Gordoa, Alejo Rodríguez-Vida, Georgia Anguera, Marc Campayo, Álvaro Pinto, Esther Martínez Ortega, Enrique Gallardo, Natalia Fernández Núñez, Iciar García-Carbonero, Oscar Reig, María José Méndez-Vidal, Ovidio Fernández-Calvo, Natalia Vidal Cassinello, Dolores Torregrosa, Ana López-Martín, Adriana Rosero, Patricia G. Valiente, Carmen Garcías de España, Miguel A. Climent, Montserrat Domenech Santasusana, Ángel Rodríguez Sánchez, Isabel Chirivella González, Ruth Afonso, Xavier García del Muro, Javier Casinello, Eva M. Fernández-Parra, Lourdes García Sánchez, Javier Afonso, Susana Hernando Polo, Úrsula Asensio
Publikováno v:
Clinical Genitourinary Cancer. 21:e166-e174
The long-term clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) and a complete response (CR) to the tyrosine kinase inhibitor (TKI) sunitinib are poorly known. The characteristics of these patients could reveal previously unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56af2d835c82b836e6a6a737be2ff3d
https://doi.org/10.1016/j.clgc.2022.11.021
https://doi.org/10.1016/j.clgc.2022.11.021
Autor:
Javier Casinello, Pablo Gajate, Laura Rodriguez, Almudena Martin, Ma Laura Villalobos, Lourdes García, Javier Espinosa, Teresa Alonso Gordoa, Juan Francisco Rodriguez, Jesús García-Donas, Isabel Gallegos, Iciar García, Carlos Aguado, Alvaro Pinto, Ana Herrero, J. A. Arranz, Maria del Prado Garrido, Edinson Caviedes, Constanza Maximiano, Enrique Grande, Javier Puente
Publikováno v:
Kidney Cancer. 3:41-50
Non-clear cell renal cell carcinoma (nccRCC) represents a group of multiple histologic subtypes, with different clinical outcomes and an uncertain optimal treatment. Data collected in clear cell tumors are routinely extrapolated to nccRCC, despite a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f83c653a5fb33ada876a1d764add502b
https://doi.org/10.3233/kca-180045
https://doi.org/10.3233/kca-180045
Autor:
Juan José Bretón García, Joan Maurel Santasusana, Pedro Sánchez Rovira, Javier Sastre Valera, Ignacio García Ribas, Javier Gallego Plazas, F. J. Delgado, Alfredo Carrato Mena, Jesús Florián Jericó, Ana Isabel León Carbonero, José Luis García López, Javier Casinello Espinosa, Enrique Aguilar, Marta Llanos Muñoz, Carlos Fernández Martos, Ma Carmen Galán Guzmán
Publikováno v:
Clinical and Translational Oncology. 7:493-498
A multi-centred, open-labelled, phase II study containing 46 patients was conducted to evaluate the clinical benefit of gemcitabine (1,400 mg/m2) combined with 5-FU (3 g/m2) in a 48 h continuous infusion (CI). Both drugs were administered on days 1,8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6d01fa45ed60f1794d6675afa05402
https://doi.org/10.1007/bf02717002
https://doi.org/10.1007/bf02717002
Autor:
José Luis García-Puche, Ana María Lozano, Amadeu Pelegrí, Enrique Aranda, Ana Balil, A. Oltra, Antonio Casado, Ramón Pérez-Carrión, Eduardo Díaz-Rubio, María Dolores Menéndez, María del Carmen Talavera, Emilio Alba, Álvaro Rodríguez-Lescure, José Antonio Virizuela, Miguel Martin, Javier Casinello
Publikováno v:
Scopus-Elsevier
Purpose. To determine the efficacy of high-dose consolidation DICEP chemotherapy (HD-DICEP) in prolonging progression free survival (PFS) of chemotherapy-responsive metastatic breast cancer (MBC) patients with monotopic disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bab30858680973d27b18ec319ec131
https://doi.org/10.1007/bf02712849
https://doi.org/10.1007/bf02712849
Autor:
Javier Casinello, Carlos Camps, Yolanda Escobar, J Antonio Virizuela, Isabel Sánchez-Magro, Andrés Stern
Publikováno v:
Pain management. 1(6)
SUMMARY Aim:This study evaluated health outcomes in patients with cancer pain during treatment with transdermal buprenorphine, including quality of life, effectiveness, tolerability, and functional consequences for patients and their carers. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a4aadfbedf46c7800b66addb779e96
https://pubmed.ncbi.nlm.nih.gov/24645762
https://pubmed.ncbi.nlm.nih.gov/24645762
Autor:
Santasusana JM; Departamento de Oncología Médica, Hospital Clínic, Barcelona, Spain., García López JL, García JJ, Carbonero AI, Plazas JG, Rovira PS, Martos CF, Guzmán MC, Jericó JF, Delgado FJ, Espinosa JC, Muñoz ML, Aguilar EA, Valera JS, García Ribas I, Mena AC
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2005 Dec; Vol. 7 (11), pp. 493-8.